Briefs: Venus Remedies and GPT Healthcare
News

Briefs: Venus Remedies and GPT Healthcare

Venus Remedies secures marketing authorization in Philippines

  • By IPP Bureau | December 07, 2024

Venus Remedies secures marketing authorization in Philippines

Venus Remedies Limited is pleased to announce the grant of Marketing Authorization for Pemetrexed 500 mg, a chemotherapeutic agent widely used in the treatment of lung cancer and mesothelioma, in the Philippines. This authorization marks a significant milestone in the company's journey to strengthen its presence in the high-growth Southeast Asian pharmaceutical market.

GPT Healthcare enters into MoU for new hospital at Jamshedpur

GPT Healthcare Limited has entered into Memorandum of Understanding (MOU) / Letter of Intent (LOI) for Construction and Finishing of a State-of-Art High Class Hospital Building at Jamshedpur to be let out on Lease with Naveen Singh & Others.

Upcoming E-conference

Other Related stories

Startup

Digitization